SODIUM PHENYLACETATE AND SODIUM BENZOATE
- Product NDC
- 68682-001
- 11-digit product format
- 686820001
- Labeler code
- 68682
- Product ID
- 68682-001_9c478558-474f-487f-bde2-1ebdc80f1ee3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SODIUM PHENYLACETATE AND SODIUM BENZOATE
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Oceanside Pharmaceuticals
- Application
- NDA020645
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2017-03-15
- Marketing end
- 0000-00-00
- Substance
- SODIUM PHENYLACETATE; SODIUM BENZOATE
- Active strength
- 100 mg/mL; mg/mL
- Pharmacologic classes
- Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68682-001-50 | 68682000150 | 1 VIAL, SINGLE-USE in 1 CARTON (68682-001-50) > 50 mL in 1 VIAL, SINGLE-USE | 2017-03-15 | 0000-00-00 | No | No | Current |